best glp-1 agonist companies Agonists Market Report 2025-2033, By Product, Molecule, and Geo GLP-1 Agonists Weight Loss Drugs
Description
Drugs that mimic the bodys natural GLP-1 hormone have been around since 2005, but tirzepatide was the first to target both GLP-1 and the GIP receptors, which act in synergy with GLP-1 and help stimulate insulin release
North American region is leading the GLP-1 agonists market.
While clinical innovation remains important, investors must evaluate not just scientific differentiation, but also commercial execution, payer alignment, and scalability
"The side effects for metformin are usually milder, and they resolve with time or by eating some food," Horn says
